These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 17684407)

  • 1. The genetics of lipoprotein metabolism and heart disease.
    Tai ES
    Forum Nutr; 2007; 60():110-117. PubMed ID: 17684407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apolipoprotein E in lipoprotein metabolism, health and cardiovascular disease.
    Marais AD
    Pathology; 2019 Feb; 51(2):165-176. PubMed ID: 30598326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma lipoprotein concentrations in ethnic populations.
    Watson KE
    Curr Cardiol Rep; 2003 Nov; 5(6):483-7. PubMed ID: 14558991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cholesterol fractions and apolipoproteins as risk factors for heart disease mortality in older men.
    Clarke R; Emberson JR; Parish S; Palmer A; Shipley M; Linksted P; Sherliker P; Clark S; Armitage J; Fletcher A; Collins R
    Arch Intern Med; 2007 Jul; 167(13):1373-8. PubMed ID: 17620530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated remnant cholesterol causes both low-grade inflammation and ischemic heart disease, whereas elevated low-density lipoprotein cholesterol causes ischemic heart disease without inflammation.
    Varbo A; Benn M; Tybjærg-Hansen A; Nordestgaard BG
    Circulation; 2013 Sep; 128(12):1298-309. PubMed ID: 23926208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cholesterol, lipoproteins, and coronary heart disease in women.
    Bush TL; Fried LP; Barrett-Connor E
    Clin Chem; 1988; 34(8B):B60-70. PubMed ID: 3042201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The metabolic impact of oral contraceptives.
    Krauss RM; Burkman RT
    Am J Obstet Gynecol; 1992 Oct; 167(4 Pt 2):1177-84. PubMed ID: 1415443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insights into blood lipids from rare variant discovery.
    Schmidt EM; Willer CJ
    Curr Opin Genet Dev; 2015 Aug; 33():25-31. PubMed ID: 26241468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relation of lipoprotein(a) in 11- to 19-year-old adolescents to parental cardiovascular heart disease.
    Vella JC; Jover E
    Clin Chem; 1993 Mar; 39(3):477-80. PubMed ID: 8448860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic determinants of plasma lipoproteins.
    Pollex RL; Hegele RA
    Nat Clin Pract Cardiovasc Med; 2007 Nov; 4(11):600-9. PubMed ID: 17957207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apolipoprotein E polymorphism and cardiovascular disease: a HuGE review.
    Eichner JE; Dunn ST; Perveen G; Thompson DM; Stewart KE; Stroehla BC
    Am J Epidemiol; 2002 Mar; 155(6):487-95. PubMed ID: 11882522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. JCL roundtable: Lessons from genetic variants altering lipoprotein metabolism.
    Brown WV; Ference BA; Kathiresan S
    J Clin Lipidol; 2016; 10(3):448-57. PubMed ID: 27206929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ionizing radiation and genetic risks. VI. Chronic multifactorial diseases: a review of epidemiological and genetical aspects of coronary heart disease, essential hypertension and diabetes mellitus.
    Sankaranarayanan K; Chakraborty R; Boerwinkle EA
    Mutat Res; 1999 Jan; 436(1):21-57. PubMed ID: 9878681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive value of remnant lipoprotein for cardiovascular events in patients with coronary artery disease after achievement of LDL-cholesterol goals.
    Nakamura T; Obata JE; Hirano M; Kitta Y; Fujioka D; Saito Y; Kawabata K; Watanabe K; Watanabe Y; Mishina H; Kugiyama K
    Atherosclerosis; 2011 Sep; 218(1):163-7. PubMed ID: 21605862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic Variants and Systemic Complement Activation Levels Are Associated With Serum Lipoprotein Levels in Age-Related Macular Degeneration.
    Paun CC; Ersoy L; Schick T; Groenewoud JM; Lechanteur YT; Fauser S; Hoyng CB; de Jong EK; den Hollander AI
    Invest Ophthalmol Vis Sci; 2015 Dec; 56(13):7766-73. PubMed ID: 26641553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of aerobic exercise on lipids and lipoproteins.
    Wang Y; Xu D
    Lipids Health Dis; 2017 Jul; 16(1):132. PubMed ID: 28679436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of triglyceride-rich lipoproteins-related markers and low-density lipoprotein heterogeneity with cardiovascular risk: effectiveness of polyacrylamide-gel electrophoresis as a method of determining low-density lipoprotein particle size.
    Tani S; Matsumoto M; Nagao K; Hirayama A
    J Cardiol; 2014 Jan; 63(1):60-8. PubMed ID: 24016623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetics of lipoprotein abnormalities associated with coronary artery disease susceptibility.
    Breslow JL
    Annu Rev Genet; 2000; 34():233-254. PubMed ID: 11092828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adaptive genetic variation and heart disease risk.
    Parnell LD; Lee YC; Lai CQ
    Curr Opin Lipidol; 2010 Apr; 21(2):116-22. PubMed ID: 20154611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of medical genetics on research and practices in the area of cardiovascular disease.
    Berg K
    Clin Genet; 1989 Nov; 36(5):299-312. PubMed ID: 2532083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.